ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 59 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $760,796 | +32.7% | 66,445 | +19.1% | 0.00% | – |
| Q2 2023 | $573,367 | +140.7% | 55,775 | +80.8% | 0.00% | – |
| Q1 2023 | $238,216 | +6.3% | 30,857 | +1.2% | 0.00% | – |
| Q4 2022 | $224,094 | +30.3% | 30,489 | +27.4% | 0.00% | – |
| Q3 2022 | $172,000 | -52.9% | 23,939 | -44.2% | 0.00% | – |
| Q2 2022 | $365,000 | +78.0% | 42,916 | +87.8% | 0.00% | – |
| Q1 2022 | $205,000 | +10.8% | 22,850 | +70.8% | 0.00% | – |
| Q4 2021 | $185,000 | +65.2% | 13,379 | +26.5% | 0.00% | – |
| Q1 2021 | $112,000 | – | 10,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |